Literature DB >> 7879609

Unusual case of corticobasal degeneration with tau/Gallyas-positive neuronal and glial tangles.

D S Horoupian1, P L Chu.   

Abstract

A 74-year-old woman with corticobasal degeneration (CBD) had a 9-year history of progressive loss of strength and rigidity of her right hand and then arm, followed by speech difficulties, dyskinesia, rigidity, spasticity and weakness of the ipsilateral lower limb, ultimately also involving the opposite side. She later developed supranuclear gaze palsy. Her memory remained intact during most of the duration of her disease. Laboratory tests and anti-Parkinsonian medications were not helpful. At autopsy, frontal lobe atrophy, discoloration of putamen (Pt) and pallor of substantia nigra (Sn) were observed. Neuronal loss and gliosis were extensive in motor cortex and milder in frontal cortex, abruptly ending at the central sulcus and junction of cingulate gyrus. "Achromatic" neurons were present. Neuronal loss and gliosis were seen in Pt and Sn and corticobasal inclusions in Sn. Numerous Gallyas/tau-positive, Bielschowsky/ubiquitin-negative coil, sickle, or coma-shaped tangles and thread-like processes were found in affected cortex, Pt and Sn. Some of the tangles were in neurons, but most occurred in astroglia, and their processes. The presence of Gallyas/tau-positive glia in CBD may have the same diagnostic significance as in progressive supranuclear palsy, analogous to the argyrophilic ubiquinated inclusions in oligodendroglia in multisystem atrophy. We suggest that in CBD: (1) cytoskeletal protein metabolism in neurons and glia can simultaneously be perturbed in certain neurodegenerative diseases, and (2) the astrocytosis in CBD may not be simply a reactive process but an integral part of the disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7879609     DOI: 10.1007/bf00296499

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  29 in total

Review 1.  Corticobasal degeneration.

Authors:  P D Thompson; C D Marsden
Journal:  Baillieres Clin Neurol       Date:  1992-11

Review 2.  Corticonigral degeneration with neuronal achromasia and basal neurofibrillary tangles.

Authors:  W Paulus; M Selim
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

3.  Neurofibrillary tangles in Alzheimer's disease and progressive supranuclear palsy: antigenic similarities and differences. Microtubule-associated protein tau antigenicity is prominent in all types of tangles.

Authors:  C Bancher; H Lassmann; H Budka; I Grundke-Iqbal; K Iqbal; G Wiche; F Seitelberger; H M Wisniewski
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

4.  Widespread distribution of tau in the astrocytic elements of glial tumors.

Authors:  M Miyazono; T Iwaki; T Kitamoto; R W Shin; M Fukui; J Tateishi
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

5.  Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome).

Authors:  M I Papp; J E Kahn; P L Lantos
Journal:  J Neurol Sci       Date:  1989-12       Impact factor: 3.181

6.  Corticodentatonigral degeneration with neuronal achromasia.

Authors:  J J Rebeiz; E H Kolodny; E P Richardson
Journal:  Arch Neurol       Date:  1968-01

7.  Appearance of paired nucleated, Tau-positive glia in patients with progressive supranuclear palsy brain tissue.

Authors:  T Yamada; P L McGeer; E G McGeer
Journal:  Neurosci Lett       Date:  1992-01-20       Impact factor: 3.046

8.  Glial fibrillary tangles with straight tubules in the brains of patients with progressive supranuclear palsy.

Authors:  M Nishimura; Y Namba; K Ikeda; M Oda
Journal:  Neurosci Lett       Date:  1992-08-31       Impact factor: 3.046

9.  Distribution of cortical neurofibrillary tangles in progressive supranuclear palsy: a quantitative analysis of six cases.

Authors:  P R Hof; A Delacourte; C Bouras
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

10.  Progressive supranuclear palsy: clinico-pathological and biochemical studies.

Authors:  K Jellinger; P Riederer; M Tomonaga
Journal:  J Neural Transm Suppl       Date:  1980
View more
  3 in total

1.  Corticobasal degeneration with neither argyrophilic inclusions nor tau abnormalities: a new subgroup?

Authors:  K Kawasaki; K Iwanaga; K Wakabayashi; M Yamada; H Nagai; J Idezuka; Y Homma; F Ikuta
Journal:  Acta Neuropathol       Date:  1996       Impact factor: 17.088

Review 2.  Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration.

Authors:  D W Dickson
Journal:  J Neurol       Date:  1999-09       Impact factor: 4.849

3.  Measuring disease progression in corticobasal syndrome.

Authors:  Nancy Huang; Michael Hornberger; John R Hodges; James R Burrell
Journal:  J Neurol       Date:  2014-06-04       Impact factor: 4.849

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.